Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure With Ejection Fraction Between 25% and 45%: FIX-HF-5C

NCT01381172 is registered in ClinicalTrials.gov with Impulse Dynamics as lead sponsor.

NCT NCT01381172
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01381172 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure With Ejection Fraction Between 25% and 45%: FIX-HF-5C
Lead sponsor
Impulse Dynamics
Phase
Not applicable
Overall status
Completed
Start date
January 31, 2011
Completion date
March 19, 2019
Enrollment
160 (actual)
Sites
42

Conditions

As the registry lists them; a condition with its own page is linked.

nyha class iii heart failure, nyha class iv heart failure